Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1986 1
1987 2
1988 2
1991 2
1992 1
1993 1
1994 11
1995 8
1996 3
1997 8
1998 11
1999 7
2000 8
2001 12
2002 9
2003 10
2004 16
2005 14
2006 13
2007 9
2008 14
2009 7
2010 14
2011 19
2012 17
2013 15
2014 17
2015 11
2016 10
2017 10
2018 11
2019 8
2020 10
2021 9
2022 8
2023 10
2024 3
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

317 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for remberger m
Search for Romberger M instead (3 results)
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study.
Gerbitz A, Gary R, Aigner M, Moosmann A, Kremer A, Schmid C, Hirschbuehl K, Wagner E, Hauptrock B, Teschner D, Roesler W, Spriewald B, Tischer J, Moi S, Balzer H, Schaffer S, Bausenwein J, Wagner A, Schmidt F, Brestrich J, Ullrich B, Maas S, Herold S, Strobel J, Zimmermann R, Weisbach V, Hansmann L, Lammoglia-Cobo F, Remberger M, Stelljes M, Ayuk F, Zeiser R, Mackensen A. Gerbitz A, et al. Among authors: remberger m. Front Immunol. 2023 Oct 30;14:1251593. doi: 10.3389/fimmu.2023.1251593. eCollection 2023. Front Immunol. 2023. PMID: 37965339 Free PMC article. Clinical Trial.
PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation.
Desai N, Altareb M, Remberger M, Chen C, Alfaro Moya T, Al-Shaibani E, Novitzky-Basso I, Pasic I, Lam W, Michelis FV, Gerbitz A, Viswabandya A, Kumar R, Kim DDH, Lipton JH, Mattsson J, Law AD. Desai N, et al. Among authors: remberger m. Blood Adv. 2025 Feb 11;9(3):660-669. doi: 10.1182/bloodadvances.2024014781. Blood Adv. 2025. PMID: 39565954 Free PMC article.
Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation.
Herrity E, Singhabahu S, Remberger M, Alfaro Moya T, Novitzky Basso I, Pasic I, Lam W, Law AD, Viswabandya A, Gerbitz A, Kumar R, Kim DD, Lipton JH, Mattsson J, Michelis FV. Herrity E, et al. Among authors: remberger m. Cancers (Basel). 2025 Feb 14;17(4):651. doi: 10.3390/cancers17040651. Cancers (Basel). 2025. PMID: 40002246 Free PMC article.
Allogeneic stem cell transplantation in adults 2015-21.
Vo CD, Myhre AE, Abrahamsen IW, Remberger M, Mattsson J, Fløisand Y, Grønvold BCL, Tjønnfjord GE, Tvedt THA, Gedde-Dahl T. Vo CD, et al. Among authors: remberger m. Tidsskr Nor Laegeforen. 2023 Mar 13;143(4). doi: 10.4045/tidsskr.22.0521. Print 2023 Mar 14. Tidsskr Nor Laegeforen. 2023. PMID: 36919291 Free article. English, Norwegian.
Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study.
Pasic I, Moya TA, Remberger M, Chen C, Gerbitz A, Kim DDH, Kumar R, Lam W, Law AD, Lipton JH, Michelis FV, Novitzky-Basso I, Viswabandya A, Mattsson J. Pasic I, et al. Among authors: remberger m. Transplant Cell Ther. 2024 Jul;30(7):681.e1-681.e11. doi: 10.1016/j.jtct.2024.04.014. Epub 2024 Apr 20. Transplant Cell Ther. 2024. PMID: 38648898 Free article.
Decidual stromal cells for the treatment of severe COVID-19 ARDS.
Granton J, Novitzky-Basso IN, Binnie A, Mattsson J; DSC Study Group. Granton J, et al. Intensive Care Med. 2023 Dec;49(12):1552-1554. doi: 10.1007/s00134-023-07262-x. Epub 2023 Nov 15. Intensive Care Med. 2023. PMID: 37968285 No abstract available.
Association of Cyclosporine Exposure Post-Allogeneic Hematopoietic Cell Transplant With Graft Failure and Relapse Risk in Hematological Malignancies.
Alnughmush A, Remberger M, Kulasingam V, Pasic I, Novitzky-Basso I, Law AD, Lam W, Kim DD, Gerbitz A, Kumar R, Viswabandya A, Mattsson J, Michelis FV. Alnughmush A, et al. Among authors: remberger m. Transplant Cell Ther. 2025 Sep;31(9):695.e1-695.e12. doi: 10.1016/j.jtct.2025.05.024. Epub 2025 Jun 11. Transplant Cell Ther. 2025. PMID: 40514013
Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post-Transplantation Cyclophosphamide Based GVHD Prophylaxis.
Alnughmush A, Alyamany R, Remberger M, Pasic I, Novitzky-Basso I, Law AD, Lam W, Kim DDH, Michelis FV, Gerbitz A, Kumar R, Mattsson J, Viswabandya A. Alnughmush A, et al. Among authors: remberger m. Eur J Haematol. 2025 Sep;115(3):251-259. doi: 10.1111/ejh.14438. Epub 2025 May 28. Eur J Haematol. 2025. PMID: 40437709 Free PMC article.
Effect of Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide on Graft-Versus-Host Disease Outcomes in Female Donor-to-Male Recipient Matched Unrelated Donor Allogeneic Stem Cell Transplantation for Acute Leukemia.
Desai N, Rodriguez-Rodriguez S, Remberger M, Al-Shaibani E, Alfaro-Moya T, Novitzky-Basso I, Pasic I, Michelis FV, Viswabandya A, Kim DDH, Kumar R, Mattsson J, Law AD. Desai N, et al. Among authors: remberger m. Transplant Cell Ther. 2025 Jul 13:S2666-6367(25)01322-3. doi: 10.1016/j.jtct.2025.07.010. Online ahead of print. Transplant Cell Ther. 2025. PMID: 40664263
317 results